通过离子对负μ-阿片类受体进行调节的机制
Neil J Thomson1, Ulrich Zachariae2
1Computational Biology, School of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
Structure (London, England : 1993)
|November 13, 2024
概括
离子 (Na+) 通过稳定非活性状态来负调节G蛋白合受体 (GPCRs). 这项研究揭示了Na+通过水线结合如何改变激动剂亲和力和受体信号传递.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 已知离子 (Na+) 可以负调节G蛋白合受体 (GPCR),特别是像阿片类受体 (ORs) 这样的A类受体.
- 结构研究表明,Na+在不活跃状态的GPCR中与保存的口袋结合,但在活跃状态中不结合,这表明它在受体稳定中发挥作用.
- 已知Na+结合会降低激素激剂的亲和力,并减少受体信号传递.
研究的目的:
- 研究Na+离子调节μ-片受体 (μ-OR) 的分子机制.
- 阐明Na+结合,形状变化和受体活性改变之间的联系.
主要方法:
- 使用μs-时间尺度的μ-阿片类受体 (μ-OR) 的生物分子模拟.
- 应用基于相互信息的分析来分析模拟数据.
- 检查了与Na+结合相关的结构和动态变化.
主要成果:
- +结合与连接+结合部位与激动剂结合口袋的水线相连.
- Na+ 结合会诱导受体内的极性网络的重新排列.
- 这些重新排列传播了对激动剂和G蛋白结合部位的构造变化.
结论:
- +离子通过稳定GPCRs的非活性状态,作为全调节剂.
- 确定了水线和极地网络的重新排列,为Na+介导的激动剂亲和力和信号传递的变化提供了机制性的解释.
- 这样可以更深入地了解离子对GPCR的调节.
相关概念视频
Opioid Receptors: Overview
538
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
538
Analgesia and Pain Management
518
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
518
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
230
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
230
Opioid Analgesics: Morphine and Other Natural Cogeners
185
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
185
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K


